|
Remote symptom-monitoring of patients with advanced lung cancer: A Danish national randomized controlled trial—The ProWide study. |
| |
Rasmus Blechingberg Friis |
Travel, Accommodations, Expenses - MSD Oncology |
| |
|
Research Funding - Astellas Pharma (Inst); Pfizer (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Bristol-Myers Squibb |
Consulting or Advisory Role - Novartis; Roche; Sanofi |
Research Funding - AstraZeneca; Roche; Takeda |
| |
|
|
Consulting or Advisory Role - Leo Pharma |
| |
|
Honoraria - AstraZeneca; Varian Medical Systems |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Abbvie; AstraZeneca; Pfizer; Takeda |
| |
|
Honoraria - AstraZeneca; GlaxoSmithKline; Novartis |
Consulting or Advisory Role - AstraZeneca; Roche |
Research Funding - AstraZeneca |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - Merck; Novartis |